Browsing: Pharma

Pfizer CEO Dr. Albert Bourla has yet to surpass the $33 million he earned in…

GSK has secured FDA expansion of its respiratory syncytial virus vaccine Aleksby for adults aged…

Pharma trends 2026 bring surging R&D costs, regulatory volatility, and tech disruptions, but AI innovations, decentralized trials, and promising clinical pipelines offer key opportunities for drug developers.

From a 17-year development cycle to commercial launch, production has always been in Eztugo’s DNA.…

This week’s episode of “The Topline” takes a deep dive into the biopharmaceutical industry’s fourth…

The FDA has rejected Hyloris Pharmaceuticals’ antiviral drug valacyclovir, an oral suspension for infections caused…

Eli Lilly has investments in China, Japan, and South Korea. Pfizer has become obese thanks…

During their quarterly conference call, Legend Biotech executives expressed little concern about new threats to…

While much of the company’s recent focus remains on strengthening U.S. infrastructure, Eli Lilly has…

The FDA is retiring the old and introducing a new one, announcing a new adverse…